|
Deep Learning‐Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening
Cédric de Almeida Braga
,
Maxence Bauvais
,
Pierre Sujobert
,
Maël Heiblig
,
Maxime Jullien
Journal articles
hal-04778186v1
|
|
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry
Benjamin de Valence
,
Marion Delaune
,
Yann Nguyen
,
Vincent Jachiet
,
Mael Heiblig
Journal articles
hal-04888392v1
|
|
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study.
Josquin Moraly
,
Julien Rossignol
,
Claire Rouzaud
,
Thomas Gabas
,
Hassiba Bouktit
American Journal of Hematology, 2024, American Journal of Hematology, 99 (6), pp.1095-1102. ⟨10.1002/ajh.27323⟩
Journal articles
hal-04691823v1
|
|
Histological characterization of liver involvement in systemic mastocytosis.
Julien Rossignol
,
Danielle Canioni
,
Achille Aouba
,
Cristina Bulai-Livideanu
,
Stéphane Barete
Journal articles
hal-04685730v1
|
|
Human myeloid differentiation by BMP4 signaling through the VDR pathway in acute myeloid leukemia
Florence Zylbersztejn
,
Iryna Byelinska
,
Sandrine Jeanpierre
,
Léa Barral
,
Kevin Geistlich
Journal articles
hal-04675664v1
|
|
Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C‐finding treated with midostaurin
Maël Heiblig
,
Clément Gourguechon
,
Philippe Guilpain
,
Cristina Bulai-Livideanu
,
Stéphane Barete
Journal articles
inserm-04902870v1
|
|
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Jerome Hadjadj
,
Yann Nguyen
,
Dalila Mouloudj
,
Rim Bourguiba
,
Mael Heiblig
Journal articles
hal-04711359v1
|
|
Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT.
Carmelo Gurnari
,
Linda Koster
,
Laurien Baaij
,
Mael Heiblig
,
Ibrahim Yakoub-Agha
Journal articles
hal-04672729v1
|
|
Nonischemic Cardiac Manifestations in VEXAS Syndrome
Marie Robert
,
Alexis Mathian
,
Valentin Lacombe
,
Hervé Lobbes
,
Léopold Adélaïde
Journal articles
hal-04888717v1
|
|
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Loic Vasseur
,
Laurène Fenwarth
,
Jérôme Lambert
,
Stéphane de Botton
,
Martin Figeac
Journal articles
hal-04106615v1
|
|
Mutational Profile and Dynamics of PPM1D -Mutant Clones in the Spectrum of Myeloid Disorders
Jean Pegliasco
,
David Fandrei
,
Florence Pasquier
,
Nathalie Ibrahim
,
Maria Kfoury
Journal articles
hal-04356640v1
|
|
VEXAS: where do we stand 2 years later?
Pierre Sujobert
,
Maël Heiblig
,
Yvan Jamilloux
Journal articles
hal-04906810v1
|
|
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
Ève Zakine
,
Loula Papageorgiou
,
Rim Bourguiba
,
Arsène Mekinian
,
Benjamin Terrier
Journal articles
hal-04193759v1
|
|
From vacuoles to VEXAS
Maël Heiblig
,
Pierre Sujobert
Journal articles
hal-04906677v1
|
|
Chronic myelomonocytic leukemia transdifferentiation landscape: From histiocytosis to blastic plasmacytoid dendritic cell neoplasm
Gabriel Antherieu
,
Marie Donzel
,
Brigitte Balme
,
Alexandra Traverse-Glehen
,
Maël Heiblig
Journal articles
hal-04906261v1
|
|
Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33 Positive Acute Myeloid Leukemia: Results from a French Retrospective Observational Study
Juliette Lambert
,
Emmanuel Raffoux
,
Delphine Lebon
,
Thorsten Braun
,
Mael Heiblig
Journal articles
hal-04355381v1
|
|
Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
Eytan Stein
,
Stephane de Botton
,
Thomas Cluzeau
,
Arnaud Pigneux
,
Jane Liesveld
Journal articles
hal-04182855v1
|
|
Impact on Outcome of Minimal Residual Disease after Hematopoietic Stem Cell Transplantation with Fludarabine, Amsacrine, and Cytosine Arabinoside-Busulfan Conditioning: A Retrospective Monocentric Study
Grégoire Le Meur
,
Adriana Plesa
,
Marie-Virginie Larcher
,
Gaëlle Fossard
,
Fiorenza Barraco
Journal articles
hal-04906736v1
|
|
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO
Pierre-Yves Dumas
,
Emmanuel Raffoux
,
Emilie Bérard
,
Sarah Bertoli
,
Marie-Anne Hospital
Journal articles
hal-04244552v1
|
|
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.
Benjamin de Valence
,
Marion Delaune
,
Yann Nguyen
,
Vincent Jachiet
,
Mael Heiblig
Journal articles
hal-04519630v1
|
|
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes
Laura Polivka
,
Marine Madrange
,
Cristina Bulai-Livideanu
,
Stéphane Barete
,
Thomas Ballul
Journal articles
hal-04339470v1
|
|
Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
Audrey da Rocha
,
Bruno Cassinat
,
Mael Heiblig
,
Christian Recher
,
Sarah Bertoli
Journal articles
hal-04355510v1
|
|
Deep Learning Based Blood Abnormalities Detection As a Tool for Vexas Syndrome Screening
Cedric de Almeida Braga
,
Maxence Bauvais
,
Pierre Sujobert
,
Mael Heiblig
,
Maxime Jullien
Journal articles
hal-04456433v1
|
|
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3 -Mutant Leukemia
Marie Sabatier
,
Rudy Birsen
,
Laura Lauture
,
Sarah Mouche
,
Paolo Angelino
Journal articles
hal-04166110v1
|
|
Antibody-based therapy for acute myeloid leukemia: a review of phase 2 and 3 trials
Xavier Thomas
,
Mohamed Elhamri
,
Alexandre Deloire
,
Maël Heiblig
Journal articles
hal-04907717v1
|
|
Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group
Elise Fournier
,
Maël Heiblig
,
Christine Lespinasse
,
Pascale Flandrin-Gresta
,
Antoine Geay
Journal articles
hal-04907143v1
|
|
Diagnosis of acute promyelocytic leukemia based on routine biological parameters using machine learning
Estelle Cheli
,
Simon Chevalier
,
Olivier Kosmider
,
Marion Eveillard
,
Nicolas Chapuis
Journal articles
hal-04907070v1
|
|
Pleuropulmonary manifestations of VEXAS syndrome
Raphael Borie
,
Marie-Pierre Debray
,
Alexis F. Guedon
,
Arsène Mekinian
,
Louis Terriou
Journal articles
hal-04498358v1
|
|
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
Peter-Martin Bruch
,
Sascha Dietrich
,
Herve Finel
,
Ariane Boumendil
,
Hildegard Greinix
Journal articles
hal-04922926v1
|
|
Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
Anne-Marie Daull
,
Valérie Dubois
,
Hélène Labussière-Wallet
,
Fabienne Venet
,
Fiorenza Barraco
Journal articles
inserm-04010303v1
|
|
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Maël Heiblig
,
Marcela Ferrada
,
Matthew Koster
,
Thomas Barba
,
Mathieu Gerfaud-Valentin
Journal articles
hal-04907677v1
|
|
How to Transform an Exceptional Case Report Into a Therapy: Following the Frog Out of the Box
Maël Heiblig
,
Vincent Alcazer
,
Adriana Plesa
,
Hélène Labussière-Wallet
,
Pierre Sujobert
Journal articles
hal-04908718v1
|
|
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming
Sylvain Carras
,
Dimitri Chartoire
,
Sylvain Mareschal
,
Maël Heiblig
,
Antoine Marçais
Journal articles
inserm-03280949v1
|
|
Toward a pathophysiology inspired treatment of VEXAS syndrome
Maël Heiblig
,
Bhavisha Patel
,
Emma Groarke
,
Estelle Bourbon
,
Pierre Sujobert
Journal articles
hal-04908739v1
|
|
Azacitidine for patients with Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry
Thibault Comont
,
Mael Heiblig
,
Etienne Riviere
,
Louis Terriou
,
Julien Rossignol
Journal articles
hal-04481451v1
|
|
Performances of Targeted RNA Sequencing for the Analysis of Fusion Transcripts, Gene Mutation, and Expression in Hematological Malignancies
Sandrine Hayette
,
Béatrice Grange
,
Maxime Vallee
,
Claire Bardel
,
Sarah Huet
Journal articles
hal-04382990v1
|
|
Therapeutic options in VEXAS syndrome: insights from a retrospective series
Estelle Bourbon
,
Maël Heiblig
,
Mathieu Gerfaud Valentin
,
Thomas Barba
,
Cécile-Audrey Durel
Journal articles
hal-04908402v1
|
|
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
Mael Heiblig
,
Nicolas Duployez
,
Alice Marceau
,
Delphine Lebon
,
Laure Goursaud
Journal articles
hal-03606391v1
|
|
Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication
Gabriel Antherieu
,
Audrey Bidet
,
Sarah Huet
,
Sandrine Hayette
,
Marina Migeon
Journal articles
hal-04908304v1
|
|
Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively
Maël Heiblig
,
Nicolas Duployez
,
Alice Marceau
,
Delphine Lebon
,
Laure Goursaud
Journal articles
hal-03606389v1
|
|
Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RAR alpha Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Eytan M. Stein
,
Stephane de Botton
,
Thomas Cluzeau
,
Arnaud Pigneux
,
Jane L. Liesveld
Journal articles
hal-03606393v1
|
|
Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience
Maël Heiblig
,
Hélène Labussière-Wallet
,
Franck Emmanuel Nicolini
,
Mauricette Michallet
,
Sandrine Hayette
Journal articles
hal-04908088v1
|
|
Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study
Maël Heiblig
,
Delphine Rea
,
Marie-Lorraine Chrétien
,
Aude Charbonnier
,
Philippe Rousselot
Journal articles
hal-01927788v1
|
|
The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment
Xavier Thomas
,
Maël Heiblig
Journal articles
hal-01796194v1
|